The total sales of prescription drugs in the period between January and May was $58.48 billion, up 6% on the like, year-earlier period, reports IMS International.
Italy saw the greatest growth which was up 13% to $3.8 billion. Growth in the UK rose 11% to $2.7 billion, followed by Spain and Belgium, which had sales of $2.2 billion (up 10%) and $854 million (up 9%), respectively. Germany rose 7% to $7.1 billion, France was up 6% to $6.4 billion, while the Netherlands grew 4% to $858 million. The top seven European countries totaled sales of $23.9 billion, an increase of 8% on the same period in 1995. Sales in the USA increased by 6% to $23.5 billion, with Canada up 4% to $1.5 billion. Japan saw 1% growth with sales of $9.6 million, following a flat period after the first four months (Marketletter August 5).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze